Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Winston

Showing results (1-10 of 241) with videos related to

Pageof 25
Sort By:
Current Opinion in Infectious Diseases|December 6, 2024
Risk factors for cognitive decline in persons with HIVMerle Henderson, Alan Winston
Journal of the International AIDS Society|November 14, 2014
Cerebrospinal-fluid exposure of efavirenz and its major metabolites when dosed at 400 and 600 mg once daily; a randomized controlled trialAlan Winston, Rebekah Puls
AIDS (London, England)|February 28, 2024
Could humoral immune responses to herpesviruses be a pathogenic driver of cognitive disorders in persons with HIV?Alan Winston, Patricia Price
Journal of HIV Therapy|June 14, 2005
New drugs for oldAlan Winston, Justin Stebbing
Current Opinion in Infectious Diseases|November 8, 2014
Emerging concepts on the use of antiretroviral therapy in older adults living with HIV infectionAlan Winston, Jonathan Underwood
Clinical and Experimental Immunology|January 12, 2022
Molecular neuroimaging of inflammation in HIVJasmini Alagaratnam, Alan Winston
Expert Opinion on Investigational Drugs|June 25, 2009
Rilpivirine: a novel non-nucleoside reverse transcriptase inhibitorLucy Garvey, Alan Winston
AIDS (London, England)|May 5, 2017
Measuring and managing cognitive impairment in HIVSam Nightingale, Alan Winston
Handbook of Clinical Neurology|April 2, 2018
NeuropharmacologyAlan Winston, Hadi Manji
International Journal of STD & AIDS|February 28, 2002
Recurrent hypersensitivity to CombivirAlan Winston, Ken McLean
Pageof 25

Showing results (1-10 of 241) with videos related to

Sort By:
Pageof 25
Current Opinion in Infectious Diseases|December 6, 2024
Risk factors for cognitive decline in persons with HIVMerle Henderson, Alan Winston
Journal of the International AIDS Society|November 14, 2014
Cerebrospinal-fluid exposure of efavirenz and its major metabolites when dosed at 400 and 600 mg once daily; a randomized controlled trialAlan Winston, Rebekah Puls
AIDS (London, England)|February 28, 2024
Could humoral immune responses to herpesviruses be a pathogenic driver of cognitive disorders in persons with HIV?Alan Winston, Patricia Price
Journal of HIV Therapy|June 14, 2005
New drugs for oldAlan Winston, Justin Stebbing
Current Opinion in Infectious Diseases|November 8, 2014
Emerging concepts on the use of antiretroviral therapy in older adults living with HIV infectionAlan Winston, Jonathan Underwood
Clinical and Experimental Immunology|January 12, 2022
Molecular neuroimaging of inflammation in HIVJasmini Alagaratnam, Alan Winston
Expert Opinion on Investigational Drugs|June 25, 2009
Rilpivirine: a novel non-nucleoside reverse transcriptase inhibitorLucy Garvey, Alan Winston
AIDS (London, England)|May 5, 2017
Measuring and managing cognitive impairment in HIVSam Nightingale, Alan Winston
Handbook of Clinical Neurology|April 2, 2018
NeuropharmacologyAlan Winston, Hadi Manji
International Journal of STD & AIDS|February 28, 2002
Recurrent hypersensitivity to CombivirAlan Winston, Ken McLean
Pageof 25